Kevin Ness
Director/Board Member at Foresite Life Sciences Corp.
Net worth: 2 M $ as of 2024-04-29
Profile
Kevin D.
Ness was the founder of QuantaLife, Inc. (founded in 2008) and 10X Genomics, Inc. (founded in 2012) where he held the titles of Director & VP-Product Development and Chief Operating & Technology Officer respectively.
He currently holds a Director position at Foresite Life Sciences Corp.
Kevin's former position was as President, Chief Executive Officer & Director at Inscripta, Inc. Kevin's education includes a doctorate from Stanford University and undergraduate and graduate degrees from the University of California, Santa Barbara.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-07 | 3,060,000 ( 4.48% ) | 2 M $ | 2024-04-29 |
Kevin Ness active positions
| Companies | Position | Start |
|---|---|---|
Foresite Life Sciences Corp.
 Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Director/Board Member | - |
Former positions of Kevin Ness
| Companies | Position | End |
|---|---|---|
Inscripta, Inc.
 Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Chief Executive Officer | 2020-10-26 |
| 10X GENOMICS, INC. | Founder | 2016-08-31 |
QuantaLife, Inc.
 QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Founder | 2012-08-31 |
Training of Kevin Ness
| Stanford University | Doctorate Degree |
| University of California, Santa Barbara | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| 10X GENOMICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Inscripta, Inc.
Inscripta, Inc. Miscellaneous Commercial ServicesCommercial Services Inscripta, Inc. engages in the provision of precision genome engineering solutions. Its technology includes onyx platform, the MAD7 nuclease, and biosecurity. The company was founded by Ryan T. Gill, Andrew Garst, and Tanya Lipscomb and is headquartered in Boulder, CO. | Commercial Services |
QuantaLife, Inc.
QuantaLife, Inc. Miscellaneous Commercial ServicesCommercial Services QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO. | Commercial Services |
Foresite Life Sciences Corp.
Foresite Life Sciences Corp. Financial ConglomeratesFinance Foresite Life Sciences Corp. is a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in January 2021 and is headquartered in San Francisco, CA. | Finance |
- Stock Market
- Insiders
- Kevin Ness
